Tekla Capital Management as of Dec. 31, 2017
Portfolio Holdings for Tekla Capital Management
Tekla Capital Management holds 161 positions in its portfolio as reported in the December 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Gilead Sciences (GILD) | 7.0 | $181M | 2.5M | 71.64 | |
| Celgene Corporation | 6.1 | $158M | 1.5M | 104.36 | |
| Amgen (AMGN) | 5.8 | $150M | 862k | 173.90 | |
| Biogen Idec (BIIB) | 5.5 | $142M | 446k | 318.57 | |
| Johnson & Johnson (JNJ) | 4.0 | $103M | 736k | 139.72 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.7 | $97M | 644k | 149.86 | |
| Alexion Pharmaceuticals | 3.0 | $79M | 660k | 119.59 | |
| Merck & Co (MRK) | 2.9 | $74M | 1.3M | 56.27 | |
| Mylan Nv | 2.6 | $68M | 1.6M | 42.31 | |
| UnitedHealth (UNH) | 2.6 | $67M | 306k | 220.46 | |
| Incyte Corporation (INCY) | 2.5 | $66M | 693k | 94.71 | |
| Regeneron Pharmaceuticals (REGN) | 2.5 | $64M | 171k | 375.96 | |
| Illumina (ILMN) | 2.4 | $62M | 286k | 218.49 | |
| Abbott Laboratories (ABT) | 1.8 | $46M | 799k | 57.07 | |
| BioMarin Pharmaceutical (BMRN) | 1.7 | $44M | 490k | 89.17 | |
| Medtronic (MDT) | 1.6 | $41M | 506k | 80.75 | |
| Pfizer (PFE) | 1.4 | $35M | 975k | 36.22 | |
| Humana (HUM) | 1.3 | $34M | 139k | 248.07 | |
| Allergan | 1.3 | $34M | 208k | 163.58 | |
| Abbvie (ABBV) | 1.3 | $34M | 346k | 96.71 | |
| Eli Lilly & Co. (LLY) | 1.2 | $32M | 383k | 84.46 | |
| Novartis (NVS) | 1.2 | $32M | 382k | 83.96 | |
| Shire | 1.2 | $31M | 202k | 155.12 | |
| Teva Pharmaceutical Industries (TEVA) | 1.2 | $30M | 1.6M | 18.95 | |
| CVS Caremark Corporation (CVS) | 1.0 | $27M | 367k | 72.50 | |
| Thermo Fisher Scientific (TMO) | 1.0 | $26M | 138k | 189.88 | |
| Neurocrine Biosciences (NBIX) | 1.0 | $25M | 325k | 77.59 | |
| Centene Corporation (CNC) | 0.9 | $23M | 230k | 100.88 | |
| Bristol Myers Squibb (BMY) | 0.8 | $21M | 349k | 61.28 | |
| IDEXX Laboratories (IDXX) | 0.8 | $21M | 132k | 156.38 | |
| CIGNA Corporation | 0.8 | $20M | 100k | 203.09 | |
| McKesson Corporation (MCK) | 0.8 | $19M | 124k | 155.95 | |
| SPDR S&P Biotech (XBI) | 0.7 | $19M | 227k | 84.87 | |
| Sarepta Therapeutics (SRPT) | 0.7 | $19M | 334k | 55.64 | |
| Omega Healthcare Investors (OHI) | 0.6 | $16M | 580k | 27.54 | |
| AmerisourceBergen (COR) | 0.6 | $15M | 167k | 91.82 | |
| AstraZeneca (AZN) | 0.6 | $15M | 443k | 34.70 | |
| Pieris Pharmaceuticals (PIRS) | 0.6 | $15M | 2.0M | 7.55 | |
| Novo Nordisk A/S (NVO) | 0.6 | $15M | 272k | 53.67 | |
| Alnylam Pharmaceuticals (ALNY) | 0.6 | $15M | 115k | 127.05 | |
| Sabra Health Care REIT (SBRA) | 0.5 | $14M | 725k | 18.77 | |
| Nevro (NVRO) | 0.5 | $13M | 195k | 69.04 | |
| Jazz Pharmaceuticals (JAZZ) | 0.5 | $13M | 98k | 134.65 | |
| Diplomat Pharmacy | 0.5 | $13M | 641k | 20.07 | |
| GlaxoSmithKline | 0.5 | $13M | 359k | 35.47 | |
| Senior Housing Properties Trust | 0.5 | $12M | 647k | 19.15 | |
| Seattle Genetics | 0.5 | $12M | 224k | 53.50 | |
| Exelixis (EXEL) | 0.5 | $12M | 389k | 30.40 | |
| Medical Properties Trust (MPW) | 0.5 | $12M | 859k | 13.78 | |
| Acceleron Pharma | 0.5 | $12M | 283k | 42.44 | |
| Welltower Inc 6.50% pfd prepet | 0.5 | $12M | 200k | 59.87 | |
| Sage Therapeutics (SAGE) | 0.4 | $11M | 68k | 164.71 | |
| Aegerion Pharmaceuticals 2% Du cvbond | 0.4 | $10M | 13M | 0.80 | |
| Anthem (ELV) | 0.4 | $10M | 45k | 225.01 | |
| Zimmer Holdings (ZBH) | 0.4 | $9.7M | 80k | 120.67 | |
| Charles River Laboratories (CRL) | 0.4 | $9.4M | 86k | 109.45 | |
| Merus N V (MRUS) | 0.4 | $9.3M | 479k | 19.36 | |
| LTC Properties (LTC) | 0.3 | $9.1M | 210k | 43.55 | |
| Cellectis S A (CLLS) | 0.3 | $9.0M | 310k | 29.15 | |
| Amicus Therapeutics (FOLD) | 0.3 | $8.7M | 605k | 14.39 | |
| Acadia Healthcare (ACHC) | 0.3 | $8.9M | 272k | 32.63 | |
| Aetna | 0.3 | $8.6M | 48k | 180.38 | |
| Bluebird Bio (BLUE) | 0.3 | $8.4M | 47k | 178.09 | |
| Sanofi-Aventis SA (SNY) | 0.3 | $7.7M | 180k | 43.00 | |
| Alkermes (ALKS) | 0.3 | $7.9M | 144k | 54.73 | |
| Avexis | 0.3 | $7.8M | 70k | 110.67 | |
| ACADIA Pharmaceuticals (ACAD) | 0.3 | $7.4M | 246k | 30.11 | |
| Dermira | 0.3 | $7.5M | 269k | 27.81 | |
| Edwards Lifesciences (EW) | 0.3 | $7.3M | 65k | 112.70 | |
| Ultragenyx Pharmaceutical (RARE) | 0.3 | $6.9M | 149k | 46.38 | |
| Endo International (ENDPQ) | 0.3 | $7.1M | 915k | 7.75 | |
| NuVasive | 0.3 | $6.9M | 117k | 58.49 | |
| New Senior Inv Grp | 0.3 | $6.7M | 884k | 7.56 | |
| Boston Scientific Corporation (BSX) | 0.2 | $6.6M | 265k | 24.79 | |
| Uniqure Nv (QURE) | 0.2 | $6.5M | 333k | 19.59 | |
| Ionis Pharmaceuticals (IONS) | 0.2 | $6.5M | 129k | 50.30 | |
| Express Scripts Holding | 0.2 | $6.3M | 85k | 74.64 | |
| Adaptimmune Therapeutics (ADAP) | 0.2 | $6.2M | 935k | 6.68 | |
| Pra Health Sciences | 0.2 | $5.9M | 65k | 91.07 | |
| Wright Medical Group Nv | 0.2 | $5.9M | 267k | 22.20 | |
| Epizyme | 0.2 | $5.7M | 456k | 12.55 | |
| Foamix Pharmaceuticals | 0.2 | $5.6M | 930k | 6.01 | |
| Cytomx Therapeutics (CTMX) | 0.2 | $5.6M | 265k | 21.11 | |
| Hca Holdings (HCA) | 0.2 | $5.6M | 63k | 87.84 | |
| Tetraphase Pharmaceuticals | 0.2 | $5.4M | 859k | 6.30 | |
| Intercept Pharmas conv | 0.2 | $5.5M | 6.9M | 0.80 | |
| Ventas (VTR) | 0.2 | $5.3M | 88k | 60.01 | |
| Clovis Oncology | 0.2 | $5.1M | 75k | 68.00 | |
| Global Blood Therapeutics In | 0.2 | $5.1M | 130k | 39.35 | |
| Flamel Technologies Sa (AVDL) | 0.2 | $5.1M | 624k | 8.20 | |
| Ovid Therapeutics (OVID) | 0.2 | $5.3M | 536k | 9.87 | |
| Stryker Corporation (SYK) | 0.2 | $4.9M | 32k | 154.83 | |
| Galapagos Nv- (GLPG) | 0.2 | $5.0M | 53k | 93.76 | |
| Myovant Sciences | 0.2 | $5.1M | 400k | 12.64 | |
| Tesaro | 0.2 | $4.8M | 58k | 82.87 | |
| Puma Biotechnology (PBYI) | 0.2 | $4.8M | 48k | 98.86 | |
| Physicians Realty Trust | 0.2 | $4.8M | 265k | 17.99 | |
| Natera (NTRA) | 0.2 | $4.4M | 486k | 8.99 | |
| Ardelyx (ARDX) | 0.2 | $4.2M | 639k | 6.60 | |
| Valeant Pharmaceuticals Int | 0.1 | $4.0M | 192k | 20.78 | |
| Amarin Corporation (AMRN) | 0.1 | $3.8M | 956k | 4.01 | |
| Innoviva (INVA) | 0.1 | $3.5M | 249k | 14.19 | |
| Gw Pharmaceuticals Plc ads | 0.1 | $3.3M | 25k | 132.00 | |
| Perrigo Company (PRGO) | 0.1 | $3.3M | 37k | 87.16 | |
| Trillium Therapeutics, Inc. Cmn | 0.1 | $3.3M | 450k | 7.30 | |
| Egalet Corporation note 5.50% 4/1/20 | 0.1 | $3.4M | 7.0M | 0.48 | |
| Verona Pharma Plc ads (VRNA) | 0.1 | $3.3M | 275k | 11.92 | |
| Dex (DXCM) | 0.1 | $3.1M | 54k | 57.39 | |
| Ra Pharmaceuticals | 0.1 | $3.0M | 356k | 8.50 | |
| Cytokinetics (CYTK) | 0.1 | $2.9M | 350k | 8.15 | |
| Lexicon Pharmaceuticals (LXRX) | 0.1 | $2.8M | 279k | 9.88 | |
| Allergan Plc pfd conv ser a | 0.1 | $2.9M | 5.0k | 586.20 | |
| Cascadian Therapeutics | 0.1 | $2.7M | 741k | 3.70 | |
| Argenx Se (ARGX) | 0.1 | $2.9M | 47k | 63.14 | |
| Koninklijke Philips Electronics NV (PHG) | 0.1 | $2.6M | 70k | 37.80 | |
| Tenet Healthcare Corporation (THC) | 0.1 | $2.5M | 165k | 15.16 | |
| Therapeuticsmd | 0.1 | $2.5M | 420k | 6.04 | |
| Beigene (BGNE) | 0.1 | $2.6M | 26k | 97.71 | |
| Adverum Biotechnologies | 0.1 | $2.6M | 744k | 3.50 | |
| BioCryst Pharmaceuticals (BCRX) | 0.1 | $2.2M | 449k | 4.91 | |
| United Therapeutics Corporation (UTHR) | 0.1 | $2.4M | 16k | 147.97 | |
| Horizon Pharma | 0.1 | $2.4M | 163k | 14.60 | |
| Healthcare Realty Trust Incorporated | 0.1 | $2.2M | 68k | 32.12 | |
| Henry Schein (HSIC) | 0.1 | $2.2M | 31k | 69.87 | |
| Impax Laboratories | 0.1 | $2.1M | 124k | 16.65 | |
| Spark Therapeutics | 0.1 | $2.0M | 39k | 51.41 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.1 | $1.9M | 287k | 6.80 | |
| Ac Immune Sa (ACIU) | 0.1 | $2.2M | 172k | 12.80 | |
| Achillion Pharmaceuticals | 0.1 | $1.8M | 616k | 2.88 | |
| Cymabay Therapeutics | 0.1 | $1.9M | 210k | 9.20 | |
| Affimed Therapeutics B V | 0.1 | $1.8M | 1.4M | 1.30 | |
| Syndax Pharmaceuticals (SNDX) | 0.1 | $1.8M | 200k | 8.76 | |
| Protagonist Therapeutics (PTGX) | 0.1 | $1.7M | 83k | 20.80 | |
| Evolent Health (EVH) | 0.1 | $1.5M | 123k | 12.30 | |
| Intuitive Surgical (ISRG) | 0.1 | $1.4M | 3.9k | 364.94 | |
| Danaher Corporation (DHR) | 0.1 | $1.4M | 15k | 92.81 | |
| Smith & Nephew (SNN) | 0.1 | $1.4M | 40k | 35.01 | |
| HCP | 0.1 | $1.2M | 46k | 26.09 | |
| Mallinckrodt Pub | 0.1 | $1.4M | 62k | 22.55 | |
| Healthcare Tr Amer Inc cl a | 0.1 | $1.4M | 46k | 30.04 | |
| Glaukos (GKOS) | 0.1 | $1.4M | 55k | 25.65 | |
| Welltower Inc Com reit (WELL) | 0.1 | $1.4M | 21k | 63.79 | |
| Revance Therapeutics (RVNC) | 0.0 | $1.2M | 32k | 35.75 | |
| Quotient | 0.0 | $1.0M | 210k | 4.95 | |
| Xenon Pharmaceuticals (XENE) | 0.0 | $991k | 350k | 2.83 | |
| Arca Biopharma | 0.0 | $1.1M | 811k | 1.37 | |
| Community Health Systems (CYH) | 0.0 | $869k | 204k | 4.26 | |
| Novavax | 0.0 | $708k | 571k | 1.24 | |
| Coherus Biosciences (CHRS) | 0.0 | $792k | 90k | 8.80 | |
| Nanostring Technologies (NSTGQ) | 0.0 | $555k | 74k | 7.47 | |
| Xencor (XNCR) | 0.0 | $438k | 20k | 21.90 | |
| Auris Med Hldg | 0.0 | $457k | 775k | 0.59 | |
| Bellicum Pharma | 0.0 | $505k | 60k | 8.42 | |
| Rmr Group Inc cl a (RMR) | 0.0 | $441k | 7.4k | 59.27 | |
| Global Medical Reit (GMRE) | 0.0 | $602k | 73k | 8.20 | |
| Cardinal Health (CAH) | 0.0 | $386k | 6.3k | 61.27 | |
| Celldex Therapeutics | 0.0 | $301k | 106k | 2.84 | |
| Quorum Health | 0.0 | $148k | 24k | 6.24 | |
| Alliqua Biomedical | 0.0 | $302k | 165k | 1.83 | |
| Karyopharm Therapeutics (KPTI) | 0.0 | $0 | 20.00 | 0.00 | |
| Zafgen | 0.0 | $61k | 13k | 4.58 |
